1 – 21 of 21
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis From SCAAR
(
- Contribution to journal › Article
- 2020
-
Mark
Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction
(
- Contribution to journal › Article
-
Mark
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
(
- Contribution to journal › Article
- 2019
-
Mark
Intracoronary near-infrared spectroscopy and the risk of future cardiovascular events
(
- Contribution to journal › Article
-
Mark
Peripheral artery disease and outcomes in patients with acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Peripheral Artery Disease In Patients With Acute Myocardial Infarction
2019) The American College of Cardiology 68th Annual Scientific Sessions In Journal of the American College of Cardiology 73(9 Suppl 1). p.23-23(
- Contribution to journal › Published meeting abstract
-
Mark
The effect of schizophrenia on major adverse cardiac events, length of hospital stay, and prevalence of somatic comorbidities following acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial
(
- Contribution to journal › Article
-
Mark
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve : A Substudy From the iFR-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction.
(
- Contribution to journal › Article
- 2017
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Diabetic patients with acute coronary syndromes in contemporary European registries : Characteristics and outcomes
(
- Contribution to journal › Article
-
Mark
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study
(
- Contribution to journal › Article
-
Mark
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : A Swedish nationwide observational study
(
- Contribution to journal › Article
-
Mark
Intravascular Ultrasound Guidance is Associated with Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared with Angiography Guidance Alone
(
- Contribution to journal › Article
- 2016
-
Mark
P2Y12 receptor inhibitors in patients with non-STelevation acute coronary syndrome in the real world : Use, patient selection, and outcomes from contemporary European registries
(
- Contribution to journal › Article
-
Mark
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
(
- Contribution to journal › Article